FrancophonIA/ELRC3.0 huggingface dataset:
English: In many cases the presence of pre-existing mitochondrial impairment (genetic disease, liver enzyme abnormalities, infection with hepatitis B or hepatitis C virus, alcohol abuse, anorexia concomitant use of other potentially hepatotoxic medicines) and ongoing injecting drug use may have a causative or contributory role.
Croatian: infekcije virusom hepatitisa B ili C, alkoholizma, anoreksije, uz istovremenu primjenu drugih potencijalno hepatotoksičnih lijekova) i aktualna intravenska uporaba sredstava ovisnosti mogli su prouzročiti ove promjene ili im doprinijeti.
English: The recommended starting dose for adults and adolescents over the age of 15 years is one to two tablets of Suboxone 2 mg/0.5 mg. An additional one to two tablets of the Suboxone 2 mg/0.5 mg may be administered on day 1 depending on your needs.
Croatian: Dodatno se može uzeti jedna ili dvije tablete lijeka Suboxonea od 2 mg/0,5 mg prvog dana, ovisno o Vašim potrebama.
English: INFORMATION IN BRAILLE Suboxone 16 mg/4 mg sublingual tablets
Croatian: Suboxone 16 mg/4 mg sublingvalne tablete
English: Package leaflet: Information for the user Suboxone 16 mg/4 mg sublingual tablets buprenorphine / naloxone
Croatian: UPUTA O LIJEKU: PODACI ZA KORISNIKA Suboxone 16 mg/4 mg sublingvalne tablete buprenorfin/nalokson
English: INFORMATION IN BRAILLE Suboxone 2 mg/0.5 mg sublingual tablets
Croatian: Suboxone 2 mg/0,5 mg sublingvalne tablete
English: Patients should be cautioned about driving or operating hazardous machinery in case buprenorphine/naloxone may affect their ability to engage in such activities.
Croatian: Bolesnike treba upozoriti da buprenorfin/nalokson može utjecati na njihovu sposobnost upravljanja vozilima i rada na teškim strojevima.
English: Sublingual tablet White hexagonal biconvex tablets of 6.5 mm with “N2” debossed on one side.
Croatian: Bijele heksagonalne bikonveksne tablete promjera 6,5 mm s "N2" utisnutim na jednoj strani.
English: Each sublingual tablet contains 16 mg buprenorphine (as hydrochloride) and 4 mg naloxone (as hydrochloride dihydrate).
Croatian: Svaka sublingvalna tableta sadrži 16 mg buprenorfina (kao hidroklorid) i 4 mg naloksona (kao hidroklorid dihidrat).
English: HU8 7DS
Croatian: HU8 7DS Ujedinjeno Kraljevstvo ili
English: Each 2 mg/0.5 mg sublingual tablet contains 2 mg buprenorphine (as hydrochloride) and 0.5 mg naloxone (as hydrochloride dihydrate).
Croatian: Svaka sublingvalna tableta od 2 mg/0,5 mg sadrži 2 mg buprenorfina (u obliku buprenorfinklorida) i 0,5 mg naloksona (u obliku naloksonklorid dihidrata).
English: AUTHORISATION
Croatian: Postupanje
English: NAME OF THE MEDICINAL PRODUCT Suboxone 8 mg/2 mg sublingual tablets
Croatian: Suboxone 8 mg/2 mg sublingvalne tablete
English: Package leaflet: Information for the user Suboxone 8 mg/2 mg sublingual tablets buprenorphine / naloxone
Croatian: UPUTA O LIJEKU: PODACI ZA KORISNIKA Suboxone 8 mg/2 mg sublingvalne tablete buprenorfin/nalokson
English: Each sublingual tablet contains 8 mg buprenorphine (as hydrochloride) and 2 mg naloxone (as hydrochloride dihydrate).
Croatian: Svaka sublingvalna tableta sadrži 8 mg buprenorfina (kao hidroklorid) i 2 mg naloksona (kao hidroklorid dihidrat).
English: other opioid containing medicines such as methadone, certain pain killers and cough suppressants anti-depressants (used to treat depression) such as isocarboxazide, phenelzine, selegiline, tranylcypromine and valproate may increase the effects of this medicine.
Croatian: drugi opioidi koji sadrže lijekove poput metadona, određeni lijekovi protiv boli i lijekovi protiv kašlja antidepresivi (koriste se za liječenje depresije) poput izokarboksazida, fenelzina, selegilina, tranilcipromina i valproata mogu povećati učinak ovih lijekova. sedativni antagonisti H1 receptora (koriste se za liječenje alergijskih reakcija) poput difenhidramina i klorfenamina. barbiturati (koriste se za uspavljivanje ili sedaciju) poput fenobarbitala, sekobarbitala trankvilizatori (koriste se za uspavljivanje ili sedaciju) poput kloralhidrata.
English: Some reports of seizure, vomiting, diarrhoea, and elevated liver function tests were considered serious.
Croatian: Ozbiljnim su smatrane neke prijave o epileptičkim napadajima, povraćanju,
English: You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Croatian: Nuspojave možete prijaviti izravno putem nacionalnog sustava za prijavu nuspojava na Internetska stranica: www.halmed.hr ili potražite HALMED aplikaciju putem Google Play ili Apple App Store trgovine Prijavljivanjem nuspojava možete pridonijeti u procjeni sigurnosti ovog lijeka.
English: The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to special and restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Croatian: Na tiskanoj uputi o lijeku mora se navesti naziv i adresa proizvođača odgovornog za puštanje navedene serije u promet.
English: Weight loss, swelling (hands and feet), drowsiness, anxiety, nervousness, tingling, depression, decreased sexual drive, increase in muscle tension, abnormal thinking, increased tearing (watering eyes) or other tearing disorder, blurred vision, flushing, increased blood pressure, migraines, runny nose, sore throat and painful swallowing, increased cough, upset stomach or other stomach discomfort, diarrhoea, abnormal liver function, flatulence, vomiting, rash, itching, hives, pain, joint pain, muscle pain, leg cramps (muscle spasm), difficulty in getting or keeping an erection, urine abnormality, abdominal pain, back pain, weakness, infection, chills, chest pain, fever, flu-like symptoms, feeling of general discomfort, accidental injury caused by loss of alertness or co-ordination, faintness and dizziness.
Croatian: Gubitak tjelesne težine, oticanje (ruku i stopala), , omamljenost, tjeskoba, nervoza, trnci, depresija, smanjen seksualni nagon, povećana napetost mišića, poremećaj razmišljanja, pojačano suzenje (vodnjikave oči) ili drugi poremećaji suzenja, zamagljen vid, navale crvenila, povišen krvni tlak, migrene, curenje iz nosa, grlobolja i bolno gutanje, pojačan kašalj, nadražen želudac ili druge nelagode želuca, proljev, poremećaj jetrene funkcije, , vjetrovi, povraćanje, osip, svrbež, koprivnjača, bol, bol u zglobovima, bol u mišićima, grčevi u nogama (grč mišića), poteškoće u postizanju i održavanju erekcije, abnormalnosti mokraće, bol u trbuhu, bol u leđima, slabost, infekcije, zimica, bol u prsištu, vrućica, simptomi nalik gripi, osjećaj opće nelagode, slučajne ozljede uzrokovane gubitkom pažnje ili koordinacije, nesvjestica i omaglica.
English: Ireland
Croatian: Croatia
English: Albuminuria Dysuria
Croatian: Prijavljivanje nuspojava
English: Each 16 mg/4 mg sublingual tablet contains 16 mg buprenorphine (as hydrochloride) and 4 mg naloxone (as hydrochloride dihydrate).
Croatian: Svaka sublingvalna tableta od 16 mg/4 mg sadrži 16 mg buprenorfina (u obliku buprenorfinklorida) i 4 mg naloksona (u obliku naloksonklorid dihidrata).
English: Side effects reported with Suboxone
Croatian: Nuspojave zabilježene s lijekom Suboxone
English: Metabolites of buprenorphine accumulate in patients with renal failure.
Croatian: bolesnika sa zatajenjem bubrega nakupljaju se metaboliti buprenorfina.
English: It is recommended that patients receiving buprenorphine/naloxone should be closely monitored if inducers (e.g. phenobarbital, carbamazepine, phenytoin, rifampicin) are co-administered.
Croatian: karbamazepina, fenitoina, rifampicina) preporučuje se pažljivo nadziranje bolesnika koji primaju buprenorfin/nalokson.
English: Package leaflet: Information for the user Suboxone 2 mg/0.5 mg sublingual tablets buprenorphine / naloxone
Croatian: Uputa o lijeku: Informacija za korsnika Suboxone 2 mg/0,5 mg sublingvalne tablete buprenorfin/nalokson
English: Asthma Dyspnoea
Croatian: Astma Dispneja Zijevanje
English: 5 How to store Suboxone Content of the pack and other information
Croatian: Sadržaj pakiranja i druge informacije Što Suboxone sadrži
English: Respiratory, thoracic and
Croatian: Poremećaji jetre i žuči
English: NAME OF THE MEDICINAL PRODUCT Suboxone 8 mg/2 mg sublingual tablets buprenorphine/naloxone
Croatian: Suboxone 8 mg/2 mg sublingvalne tablete buprenorfin/nalokson
English: MARKETING AUTHORISATION NUMBER(S) EU/1/06/359/005
Croatian: BROJ(EVI) ODOBRENJA ZA STAVLJANJE GOTOVOG LIJEKA U PROMET EU/1/06/359/005
English: MARKETING AUTHORISATION NUMBER(S) EU/1/06/359/005 16 mg sublingual tablets 7
Croatian: 12. BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/06/359/005 7 sublingvalnih tableta od 16 mg EU/1/06/359/006 28 sublingvalnih tableta od 16 mg
English: NAME OF THE MEDICINAL PRODUCT Suboxone 16 mg/4 mg sublingual tablets buprenorphine/naloxone
Croatian: Suboxone 16 mg/4 mg sublingvalne tablete buprenorfin/nalokson
English: Each 8 mg/2 mg tablet contains 8 mg buprenorphine (as hydrochloride) and 2 mg naloxone (as hydrochloride dihydrate).
Croatian: Svaka sublingvalna tableta od 8 mg/2 mg sadrži 8 mg buprenorfina (u obliku buprenorfinklorida) i 2 mg naloksona (u obliku naloksonklorid dihidrata).
English: Each sublingual tablet contains 2 mg buprenorphine (as hydrochloride) and 0.5 mg naloxone (as hydrochloride dihydrate).
Croatian: Svaka sublingvalna tableta sadrži 2 mg buprenorfina (u obliku buprenorfinklorida) i 0,5 mg naloksona (u obliku naloksonklorid dihidrata).
English: - The active substances are buprenorphine and naloxone.
Croatian: - Djelatne tvari su buprenorfin i nalokson.
English: Severe hepatic impairment
Croatian: Hepatitis Akutni hepatitis
English: NAME OF THE MEDICINAL PRODUCT Suboxone 2 mg/0.5 mg sublingual tablets buprenorphine/naloxone
Croatian: Suboxone 2 mg/0,5 mg sublingvalne tablete buprenorfin/nalokson
English: Abdominal Pain Diarrhoea Dyspepsia Flatulence
Croatian: Bol u abdomenu Proljev
English: 1.1-fold Increase
Croatian: Povećanje od 1,1 puta
English: Caution is recommended when dosing patients with severe renal impairment (creatinine clearance < 30 ml/min) (see section 4.4 and 5.2).
Croatian: Preporučuje se oprez pri doziranju u bolesnika s teškim bubrežnim oštećenjem (klirens kreatinina < 30 ml/min)
English: Liver function test abnormal Weight decreased
Croatian: Promijenjeni nalazi funkcije jetre
English: Swollen glands (lymph nodes), agitation, tremor, abnormal dream, excessive muscle activity, depersonalisation (not feeling like yourself), medicine dependence, amnesia (memory disturbance), loss of interest, exaggerated feeling of well being, convulsion (fits), speech disorder, small pupil size, difficulty urinating, eye inflammation or infection, rapid or slow heart beat, low blood pressure, palpitations, myocardial infarction (heart attack), chest tightness, shortness of breath, asthma, yawning, pain and sores in mouth, tongue discolouration, acne, skin nodule, hair loss, dry or scaling skin, inflammation of joints, urinary tract infection, abnormal blood tests, blood in urine, abnormal ejaculation, menstrual or vaginal problems, kidney stone, protein in your urine, painful or difficult urination, sensitivity to heat or cold, heat stroke, loss of appetite feelings of hostility.
Croatian: ubrzani ili usporeni otkucaji srca, nizak krvni tlak, osjećaj lupanja srca, infarkt miokarda (srčani udar), stezanje u prsima, nedostatak zraka, astma, zijevanje, bol i ranice u ustima, promjena boje jezika, akne, kožni čvorići, gubitak kose, suha ili perutava koža, upala zglobova, infekcija mokraćnih puteva, abnormalni rezultati krvnih pretraga, krv u mokraći, poremećaji ejakulacije, menstrualni ili vaginalni problemi, bubrežni kamenci, nalaz proteina u urinu, bolno ili otežano mokrenje, osjetljivost na toplinu ili hladnoću, udar topline, gubitak apetitaosjećaj neprijateljstva.
English: Migraine Dizziness Hypertonia Paraesthesia Somnolence
Croatian: Parestezije Somnolencija
English: Asthma Dyspnoea Yawning
Croatian: Menoragija Metroragija
English: 0.2-fold decrease
Croatian: Povećanje od 0,2 puta
English: Cough
Croatian: Mioza
English: MA (EU) number (Invented) name Strength Pharmaceutical form Route of administration
Croatian: (Zaštićeno) ime Doza Farmaceutski oblik Put primjene Unutarnje pakovanje
English: EU/1/11/740/001
Croatian: EU/1/11/740/001 Ameluz
English: Cutaneous use tube (alu) 2 g
Croatian: Tuba (Al)
English: Ameluz
Croatian: Topikalna primjena
English: 5 April 2016 EMA/147173/2016
Croatian: EMA/147173/2016
English: If symptoms last longer than one week a doctor or a qualified healthcare practitioner should be consulted.
Croatian: Ako simptomi traju dulje od jednog tjedna, potrebno je obratiti se liječniku ili kvalificiranom zdravstvenom radniku.
English: Although the results from this study indicated that the horsetail herb preparation did have a mild diuretic effect, only a few individuals were included in the study and the information on the preparation used was limited.
Croatian: Iako su rezultati tog ispitivanja ukazivali na to da je pripravak od zeleni poljske preslice imao blag diuretički učinak, u ispitivanje je bilo uključeno samo nekoliko osoba, a informacije o korištenom pripravku bile su ograničene.
English: Horsetail herb medicines should be used only in adults and adolescents over the age of 12 years.
Croatian: Lijekovi koji sadrže zelen poljske preslice smiju se koristiti samo u odraslih osoba i adolescenata starijih od 12 godina.
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom production of urine in order to achieve flushing of the urinary tract.
Croatian: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom
English: Horsetail herb is the common name for the aerial parts of the plant Equisetum arvense L.
Croatian: Zelen poljske preslice je uobičajen naziv za nadzemne dijelove biljke Equisetum arvense L.
English: Any applications for the licensing of medicines containing horsetail herb have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Croatian: Svi zahtjevi za odobrenje lijekova koji sadrže zelen poljske preslice moraju se podnijeti nacionalnim tijelima nadležnima za lijekove, koja ocjenjuju zahtjev za biljni lijek i uzimaju u obzir znanstvene zaključke HMPC-a.
English: Further information on the HMPC assessment of horsetail herb medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Croatian: Daljnje informacije o HMPC-ovoj ocjeni lijekova koji sadrže zelen poljske preslice, uključujući pojedinosti zaključaka Povjerenstva, mogu se pronaći pod karticom „All documents” na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: This summary is not intended to provide practical advice on how to use medicines containing horsetail herb.
Croatian: Svrha ovog sažetka nije davati praktične savjete o načinu primjene lijekova koji sadrže zelen poljske preslice.
English: Further information on the risks associated with horsetail herb medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Croatian: Više o rizicima povezanima s lijekovima koji sadrže zelen poljske preslice, uključujući odgovarajuće mjere opreza za njihovu sigurnu primjenu, možete pronaći u monografiji pod karticom „All documents” na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: In its assessment, the HMPC considered a clinical study in healthy male volunteers comparing a horsetail herb preparation with a dummy treatment and a medicine that increases the volume of urine produced (a diuretic).
Croatian: Prilikom svoje ocjene HMPC je razmotrio kliničko ispitivanje u zdravih muških dobrovoljaca u kojem je uspoređen pripravak od zeleni poljske preslice s primanjem placeba i lijekom koji povećava količinu stvorenog urina (diuretik).
English: These include allergic reactions and, when used for minor urinary conditions, mild stomach and gut complaints.
Croatian: One uključuju alergijske reakcije i, kod primjene pri lakšim tegobama mokraćnih putova, blage želučane i crijevne tegobe.
English: The HMPC also noted the lack of clinical studies with horsetail herb for treating superficial wounds.
Croatian: HMPC je također ukazao na nedostatak kliničkih ispitivanja primjene zeleni poljske preslice za liječenje površinskih rana.
English: The HMPC conclusions only cover horsetail herb preparations which are obtained by drying and comminuting (reducing into tiny pieces) the aerial parts of the plant, by expressing the juice of the fresh aerial parts and as dry or liquid extracts from the dried aerial parts.
Croatian: Zaključcima HMPC-a obuhvaćeni su samo pripravci zeleni poljske preslice koji su dobiveni sušenjem i usitnjavanjem (smanjivanjem na manje komadiće) nadzemnih dijelova biljke, istiskivanjem soka svježih nadzemnih dijelova i u obliku suhih ili tekućih ekstrakata iz osušenih nadzemnih dijelova.
English: The HMPC concluded that, on the basis of its long-standing use, these horsetail herb preparations can be used in minor problems affecting the urinary tract (structures that carry urine) to increase the
Croatian: HMPC je zaključio da se na temelju njihove dugotrajne primjene, ovi pripravci koji sadrže zelen poljske preslice mogu koristiti u slučaju manjih problema koji zahvaćaju mokraćne putove (strukture koje prenose urin) kako bi se povećalo stvaranje urina s ciljem ispiranja mokraćnih putova.
English: Information on the use and licensing of horsetail herb medicines in EU Member States should be obtained from the relevant national authorities.
Croatian: Informacije o primjeni i davanju odobrenja za lijekove koji sadrže zelen poljske preslice u državama članicama EU-a mogu se dobiti od nadležnih nacionalnih tijela.
English: Horsetail herb preparations may also be found in combination with other herbal substances in some herbal medicines.
Croatian: Pripravci od zeleni poljske preslice mogu postojati također i u kombinaciji s drugim biljnim tvarima u nekim biljnim lijekovima.
English: Horsetail herb medicines must not be used for minor urinary complaints if a reduced fluid intake is recommended for existing conditions (e.g. severe heart or kidney disease).
Croatian: Lijekovi od zeleni poljske preslice ne smiju se primjenjivati kod lakših tegoba mokraćnih putova ako je zbog postojećih stanja preporučen smanjen unos tekućina (npr. zbog teške bolesti srca ili bubrega).
English: Extracts are prepared using a technique to extract compounds from plant material by putting the plant material in a solvent (such as ethanol or water) to dissolve compounds and form a liquid extract.
Croatian: Ekstrakti se dobivaju primjenom tehnike za ekstrakciju spojeva iz biljnog materijala stavljajući biljni materijal u otapalo (npr. u etanol ili vodu) radi otopanja spojeva i dobivanja tekućeg ekstrakta.
English: The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing horsetail herb.
Croatian: Države članice EU-a uzimaju u obzir zaključke HMPC-a prilikom ocjene zahtjeva za davanje odobrenja za biljne lijekove koji sadrže zelen poljske preslice.
English: This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of horsetail herb.
Croatian: Ovaj dokument predstavlja sažetak znanstvenih zaključaka Povjerenstva za biljne lijekove (HMPC) u pogledu medicinske primjene zeleni poljske preslice.
English: Horsetail herb preparations can also be used for treating superficial wounds.
Croatian: Pripravci od zeleni poljske preslice mogu se primjenjivati i za liječenje površinskih rana.
English: Detailed instructions on how to take horsetail herb medicines and who can use them can be found in the package leaflet that comes with the medicine.
Croatian: Detaljne upute o načinu uzimanja lijekova koji sadrže zelen poljske preslice i o tome tko ih smije uzimati navedene su u uputi o lijeku koja je priložena uz lijek.
English: What are the risks associated with horsetail herb medicines?
Croatian: Koji su rizici povezani s lijekovima koji sadrže poljsku preslicu?
English: For more information about treatment with horsetail herb medicines, read the package leaflet that comes with the medicine or contact your doctor or pharmacist.
Croatian: Za više informacija o liječenju lijekovima koji sadrže zelen poljske preslice pročitajte uputu o lijeku priloženu uz lijek, odnosno obratite se svom liječniku ili ljekarniku.
English: The HMPC conclusions on the use of horsetail herb medicines for minor urinary complaints and for superficial wounds are based on their ‘traditional use'.
Croatian: Zaključci HMPC-a o primjeni lijekova koji sadrže zelen poljske preslice kod lakših tegoba mokraćnih putova i površinskih rana temelje se na njihovoj „tradicionalnoj primjeni”.
English: The other herbal preparations of horsetail herb are available in solid or liquid forms to be taken by mouth and in liquid forms to be applied to the skin.
Croatian: Drugi biljni pripravci koji sadrže zelen poljske preslice dostupni su u krutom ili tekućem obliku i uzimaju se kroz usta, te u tekućem obliku za primjenu na kožu.
English: Herbal medicines containing comminuted horsetail herb are usually available as herbal tea to be drunk or as infusion or decoction to be applied to the skin.
Croatian: Biljni lijekovi koji sadrže usitnjenu zelen poljske preslice najčešće su dostupni kao biljni čaj koji se pije ili u obliku infuzije ili dekokta za primjenu na kožu.
English: Therefore, the HMPC conclusions on the uses of horsetail herb medicines are based on their long-standing use.
Croatian: Zaključci HMPC-a o lijekovima koji sadrže zelen poljske preslice stoga se temelje na njihovoj dugotrajnoj primjeni.
English: For practical information about using horsetail herb medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Croatian: Za praktične informacije o primjeni lijekova koji sadrže zelen poljske preslice bolesnici trebaju pročitati uputu o lijeku priloženu uz lijek, odnosno obratiti se svom liječniku ili ljekarniku.
English: Other information about horsetail herb medicines
Croatian: Ostale informacije o lijekovima koji sadrže zelen poljske preslice
English: What is horsetail herb?
Croatian: Što je zelen poljske preslice?
English: How are horsetail herb medicines approved in the EU?
Croatian: Kako se u EU-u odobravaju lijekovi koji sadrže zelen poljske preslice?
English: What evidence supports the use of horsetail herb medicines?
Croatian: Kojim se dokazima potkrjepljuje primjena lijekova koji sadrže zelen poljske preslice?
English: Side effects have been reported with horsetail herb medicines.
Croatian: Prijavljene su nuspojave prilikom primjene lijekova koji sadrže zelen poljske preslice.
English: For dry extracts the solvent is then evaporated.
Croatian: Otapalo se zatim uparava kako bi se dobio suhi ekstrakt.
English: Horsetail herb
Croatian: Zelen poljske preslice
English: More information is given below in “Other medicines and Invokana”.
Croatian: Više informacija možete pronaći niže, u dijelu “Drugi lijekovi i Invokana”.
English: Children and adolescents Invokana is not recommended for children and adolescents under 18 years.
Croatian: Primjena lijeka Invokana se ne preporučuje u djece i adolescenata ispod 18 godina.
English: • if you are allergic to canagliflozin or any of the other ingredients of this medicine (listed in section 6).
Croatian: • ako ste alergični na kanagliflozin ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.).